In addition, NRF2 has been shown to reduce ferroptosis in HCC by enhancing antioxidant proteins (such as quinone oxidoreductase 1 and heme oxygenase-1 (HO-1)) in cells [15]. This evidence concerns the gene HMOX1 and hepatocellular carcinoma.